Global Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 market

Intervention Drug Eluting Stent Market, Global Outlook and

Forecast 20222028 Market

Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 Market

Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 Market Size and Growth

The global coronary intervention drug eluting stent market is expected to reach a value of $7.2 billion by 2028, with a CAGR of 5.3% during the forecast period. Factors such as rising incidence of cardiovascular diseases and technological advancements in stent design are driving market growth. North America is projected to dominate the market, followed by Europe and Asia-Pacific.

Companies Covered

(Covid 19 Impact Covered)

◍ Synlas GmbH

◍ YILSON

◍ BrosMed Medical

◍ SCITECH Medical

◍ Wellinq

◍ Degania Silicone

◍ Alvimedica

◍ Interventional Medical Device Solutions

◍ Comed BV

◍ iVascular

◍ LEPU Medical

◍ Eurocor Tech GmbH

◍ OrbusNeich

◍ Endocor GmbH

◍ Meril Life Sciences

◍ Acrostak

◍ Boston Scientific Corporation

◍ B. Braun

The competitive landscape of the Coronary Intervention Drug Eluting Stent Market includes companies such as Synlas GmbH, YILSON, BrosMed Medical, SCITECH Medical, Wellinq, Degania Silicone, Alvimedica, Interventional Medical Device Solutions, Comed BV, iVascular, LEPU Medical, Eurocor Tech GmbH, OrbusNeich, Endocor GmbH, Meril Life Sciences, Acrostak, Boston Scientific Corporation, B. Braun, Biotronik, Abbott, MicroPort Medical Group, Philips, and Terumo Corporation. These companies provide innovative stent solutions and contribute to the growth of the market.

- Boston Scientific Corporation reported sales revenue of $10.7 billion in 2021.

- Abbott reported sales revenue of $44.8 billion in 2021.

- Biotronik reported sales revenue of $2.1 billion in 2021.

Request Sample Report

Market Segmentation

By Application

Hospital

Clinic

Others

Request Sample Report

By Product

Below 40 µm

40 µm- 65 µm

Above 65 µm

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook

Global Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 market

Published on Jul 17, 2024

ReportPrime

The global Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 market size is expected to experience a CAGR of 15.8% through 2024 - 2031, according to industry projections. Key Question Covered in this Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 Market Research Report What is the Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 market size, and what is the expected growth rate? What are the key drivers and market challenges in the market? Who are the major players in the Coronary Intervention Drug Eluting Stent Market, Global Outlook and Forecast 2022-2028 market, and what are their market shares? What are the major market trends and opportunities in the market? What are the key customer segments and their buying behavior? What are the major geographical regions contributing to the market growth?